Showing results (1-10 of 515) with videos related to
Sort By:
Pageof 52
Immunotherapy|May 11, 2016
Therapeutic anti-CD3 monoclonal antibodies: from bench to bedsideChantal Kuhn, Howard L WeinerJournal of Immunology (Baltimore, Md. : 1950)|January 1, 2017
IL-6 Inhibits Upregulation of Membrane-Bound TGF-β 1 on CD4+ T Cells and Blocking IL-6 Enhances Oral ToleranceChantal Kuhn, Rafael Machado Rezende, Hanane M'Hamdi, et al.Clinical Immunology (Orlando, Fla.)|July 26, 2017
Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized miceMineko Ogura, Songyan Deng, Paula Preston-Hurlburt, et al.Journal of Autoimmunity|October 18, 2016
Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chainChantal Kuhn, Rafael M Rezende, Andre Pires da Cunha, et al.Epilepsia|July 30, 2004
Tuberous sclerosis and multiple tubers: localizing the epileptogenic zoneHoward L WeinerJournal of the Neurological Sciences|July 21, 2004
Immunosuppressive treatment in multiple sclerosisHoward L WeinerNature Reviews. Neurology|December 16, 2024
Immune mechanisms and shared immune targets in neurodegenerative diseasesHoward L WeinerAnnals of the New York Academy of Sciences|February 1, 2005
Current issues in the treatment of human diseases by mucosal toleranceHoward L WeinerJournal of Neurology|April 9, 2008
A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosisHoward L WeinerAnnals of Neurology|April 1, 2009
The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?Howard L WeinerPageof 52